FundaMental Pharma to Present Innovative TRD Treatment in Amsterdam
FundaMental Pharma GmbH, a preclinical-stage biopharmaceutical company, will present its innovative approach to treating treatment-resistant depression (TRD) at the upcoming Bio-Neuroscience Conference. This prestigious event is set to take place…